Ottmann, Oliver G. ORCID: https://orcid.org/0000-0001-9559-1330, Müller-Tidow, Carsten, Krämer, Alwin, Schlenk, Richard F., Lübbert, Michael, Bug, Gesine, Krug, Utz, Bochtler, Tilmann, Voss, Florian, Taube, Tillmann, Liu, Dan, Garin-Chesa, Pilar and Döhner, Hartmut 2019. Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia. British Journal of Haematology 184 (6) , pp. 1018-1021. 10.1111/bjh.15204 |
Preview |
PDF
- Accepted Post-Print Version
Download (484kB) | Preview |
Official URL: http://dx.doi.org/10.1111/bjh.15204
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Medicine |
Publisher: | Wiley |
ISSN: | 0007-1048 |
Date of First Compliant Deposit: | 3 June 2019 |
Date of Acceptance: | 3 June 2018 |
Last Modified: | 07 Nov 2023 04:45 |
URI: | https://orca.cardiff.ac.uk/id/eprint/123126 |
Citation Data
Cited 21 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
Edit Item |